Organization Profile

You just read:

QVA149 ILLUMINATE Phase III COPD Study Meets Primary Endpoint and Clarification of Anticipated Timing of US Filings for NVA237 and QVA149

News provided by

Sosei Group Corporation

Apr 24, 2012, 01:51 ET